Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2020 09:00 ET | Source: Biofrontera AG

Biofrontera strengthens commercial focus with reorganization of its US business

Leverkusen, Germany, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced a new...
December 20, 2019 09:35 ET | Source: Biofrontera AG

Extraordinary General Meeting of Biofrontera AG: Biofrontera Management Board supported by large majority

Leverkusen, Germany, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...
December 13, 2019 08:20 ET | Source: Biofrontera AG

Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera Inc.

Leverkusen, Germany, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...
November 22, 2019 11:06 ET | Source: Biofrontera AG

Biofrontera to Participate in Upcoming Investor Conferences

Leverkusen, Germany, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international biopharmaceutical company, today announced its...
November 19, 2019 03:25 ET | Source: Biofrontera AG

Biofrontera Reports Third Quarter 2019 Financial Results and Revises Guidance

Leverkusen, Germany, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...
November 06, 2019 05:30 ET | Source: Biofrontera AG

Biofrontera Announces Conference Call on November 19, 2019 to Discuss Third Quarter 2019 Financial Results

Leverkusen, Germany, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
October 23, 2019 02:00 ET | Source: Biofrontera AG

Biofrontera Receives Award at Fall Clinical Dermatology Conference 2019

Leverkusen, Germany, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, was presented with...
October 10, 2019 05:15 ET | Source: Biofrontera AG

Biofrontera reports preliminary unaudited sales revenue for the first nine months of 2019

Leverkusen, Germany, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-group”), an international biopharmaceutical...
September 17, 2019 09:45 ET | Source: Biofrontera AG

Biofrontera to present at the Baader Investment Conference

Leverkusen, Germany, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced that Prof....
September 17, 2019 05:45 ET | Source: Biofrontera AG

Biofrontera Files Label Extension for Ameluz® in EU to include Treatment of Actinic Keratosis on Extremities and Trunk/Neck

Leverkusen, Germany, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, has filed a label...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right